» Authors » Haruhiko Michimata

Haruhiko Michimata

Explore the profile of Haruhiko Michimata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 22
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sumi T, Sekikawa M, Koshino Y, Nagayama D, Nagahisa Y, Matsuura K, et al.
Thorac Cancer . 2024 Jun; 15(20):1572-1581. PMID: 38828610
Background: The efficacy of anti-CTLA-4 antibody (ipilimumab) plus anti-programmed cell death 1 antibody (nivolumab) in treating advanced non-small cell lung cancer (NSCLC) is impeded by an elevated risk of severe...
2.
Sumi T, Yamada Y, Koshino Y, Watanabe H, Nagayama D, Michimata H, et al.
Respir Investig . 2023 Nov; 62(1):77-84. PMID: 37976917
Background: Transbronchial biopsy using an ultrathin bronchoscope (UTB) has a high diagnostic yield for peripheral pulmonary lesions (PPLs). When combined with peripheral transbronchial needle aspiration (pTBNA), it improves the diagnostic...
3.
Michimata H, Sumi T, Nagayama D, Koshino Y, Watanabe H, Yamada Y, et al.
Respirol Case Rep . 2023 Apr; 11(5):e01137. PMID: 37051303
Perinatal cardiomyopathy presents similarly to dilated cardiomyopathy and should be suspected in perinatal women presenting with dyspnoea, even with no previous history of heart disease.
4.
Sumi T, Takeda K, Michimata H, Nagayama D, Koshino Y, Watanabe H, et al.
Intern Med . 2023 Apr; 62(22):3381-3385. PMID: 37005268
Pneumocystis pneumonia (PCP) is an opportunistic infection that presents a ground-glass appearance in the lungs on chest radiography. Interstitial lung disease is a commonly reported adverse effect of immune checkpoint...
5.
Sumi T, Koshino Y, Michimata H, Nagayama D, Watanabe H, Yamada Y, et al.
Transl Lung Cancer Res . 2022 Oct; 11(9):1973-1976. PMID: 36248324
Background: Cytokine release syndrome (CRS) is caused by the release of inflammatory cytokines that appear during or immediately after administration of a therapeutic antibody and can cause a variety of...
6.
Sumi T, Koshshino Y, Sekikawa M, Nagahisa Y, Matsuura K, Shijubou N, et al.
Invest New Drugs . 2022 Oct; 40(6):1298-1305. PMID: 36227514
Pembrolizumab treatment is associated with a favorable prognosis in patients with non-small-cell lung cancer (NSCLC). Here, we investigated the associations among pre-treatment clinical factors, baseline overall tumor burden, and development...
7.
Sumi T, Michimata H, Nagayama D, Koshino Y, Watanabe H, Yamada Y, et al.
J Thorac Oncol . 2022 Oct; 17(10):1233-1234. PMID: 36192079
No abstract available.
8.
Michimata H, Sumi T, Keira Y, Nagayama D, Koshino Y, Watanabe H, et al.
Respirol Case Rep . 2022 Sep; 10(10):e01034. PMID: 36090021
There are more complications in transbronchial lung cryobiopsy than in a conventional transbronchial lung biopsy. Respiratory endoscopists should be aware of the potential complications, including rare complications such as hemothorax.
9.
Nagayama D, Sumi T, Keira Y, Tanaka Y, Michimata H, Koshino Y, et al.
Respirol Case Rep . 2022 Aug; 10(9):e01022. PMID: 35992555
Transesophageal ultrasound-guided bronchoscopic aspiration (EUS-B-FNA) allowed for minimally invasive and simultaneous diagnosis and evaluation of the degree of invasion by echocardiography. EUS-B-FNA may be useful for the evaluation and diagnosis...